Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-16

Clinical Trial Update: Efficacy of a Fibrin Sealant for the Prevention of Lymphocele After Lymphadenectomy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of a fibrin sealant to prevent lymphocele after lymphadenectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrin sealant (fibrin sealant)

Snippet

Sponsor: IBON JAUNARENA | Conditions: Lymphocele | Phase 3 | Status: COMPLETED